Response to Crum-Cianflone et al., syphilitic hepatitis among HIV-infected patients.
Doyle
R J
RJ
Desai
M
M
White
J
J
D000372:Agglutination Tests; D000907:Antibodies, Bacterial / Q000097:blood; D000069446:Atazanavir Sulfate; D015658:HIV Infections / Q000150:complications*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006505:Hepatitis / Q000175:diagnosis* / Q000382:microbiology*; D006716:Homosexuality; D006801:Humans; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D013587:Syphilis / Q000150:complications* / Q000175:diagnosis* / Q000276:immunology; D016896:Treatment Outcome; D014210:Treponema pallidum / Q000276:immunology / Q000302:isolation & purification
D000907:Antibodies, Bacterial; D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate